| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/14/2023 | 34.02% | Barclays | $7 → $6.5 | Upgrades | Equal-Weight → Overweight |
| 07/19/2023 | 44.33% | Morgan Stanley | $7 → $7 | Reiterates | Equal-Weight → Equal-Weight |
| 06/01/2023 | 44.33% | Barclays | $8 → $7 | Maintains | Equal-Weight |
| 05/30/2023 | 44.33% | Morgan Stanley | $7.5 → $7 | Maintains | Equal-Weight |
| 05/12/2023 | 64.95% | BMO Capital | $9 → $8 | Maintains | Market Perform |
| 04/14/2023 | 64.95% | Barclays | $9 → $8 | Maintains | Equal-Weight |
| 04/12/2023 | 54.64% | Morgan Stanley | $8.5 → $7.5 | Maintains | Equal-Weight |
| 01/27/2023 | 106.19% | Barclays | $11 → $10 | Maintains | Equal-Weight |
| 01/11/2023 | 75.26% | Morgan Stanley | $12 → $8.5 | Maintains | Equal-Weight |
| 11/17/2022 | 126.8% | Barclays | $12 → $11 | Maintains | Equal-Weight |
| 11/10/2022 | 95.88% | BMO Capital | $10 → $9.5 | Maintains | Market Perform |
| 07/28/2022 | 126.8% | BMO Capital | $12 → $11 | Maintains | Market Perform |
| 06/01/2022 | 147.42% | Barclays | → $12 | Initiates Coverage On | → Equal-Weight |
| 05/12/2022 | 147.42% | Morgan Stanley | $11 → $12 | Maintains | Equal-Weight |
| 03/17/2022 | 126.8% | Morgan Stanley | $10 → $11 | Maintains | Equal-Weight |
| 02/14/2022 | 106.19% | Morgan Stanley | $9 → $10 | Maintains | Equal-Weight |
| 12/06/2021 | 85.57% | Morgan Stanley | $7 → $9 | Maintains | Equal-Weight |
| 05/10/2021 | 44.33% | Morgan Stanley | $6 → $7 | Maintains | Equal-Weight |
| 05/10/2021 | 23.71% | BMO Capital | $5.25 → $6 | Maintains | Market Perform |
| 02/16/2021 | 23.71% | Morgan Stanley | $5 → $6 | Maintains | Equal-Weight |
| 12/14/2020 | 3.09% | Morgan Stanley | $4 → $5 | Maintains | Equal-Weight |
| 11/23/2020 | 13.4% | Stephens & Co. | $7 → $5.5 | Downgrades | Overweight → Equal-Weight |
| 01/16/2020 | — | Barclays | Initiates Coverage On | → Equal-Weight |
What is the target price for ICL Group (ICL)?
The latest price target for ICL Group (NYSE: ICL) was reported by Barclays on November 14, 2023. The analyst firm set a price target for $6.50 expecting ICL to rise to within 12 months (a possible 34.02% upside). 10 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for ICL Group (ICL)?
The latest analyst rating for ICL Group (NYSE: ICL) was provided by Barclays, and ICL Group upgraded their overweight rating.
When is the next analyst rating going to be posted or updated for ICL Group (ICL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ICL Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ICL Group was filed on November 14, 2023 so you should expect the next rating to be made available sometime around November 14, 2024.
Is the Analyst Rating ICL Group (ICL) correct?
While ratings are subjective and will change, the latest ICL Group (ICL) rating was a upgraded with a price target of $7.00 to $6.50. The current price ICL Group (ICL) is trading at is $4.85, which is out of the analyst's predicted range.